As it stands, there are two drugs that have been approved by the Food and Drug Administration to be prescribed as PrEP, an HIV prevention strategy that when taken routinely makes it virtually impossible to contract the virus. Both of these daily drugs, Truvada and Descovy, are manufactured by Gilead. In the last couple years,...
Tag: <span>Truvada</span>
Post
Generic version of Truvada available in U.S. by September 2020
(HealthDay)—A generic version of the HIV preexposure prophylaxis (PrEP) drug Truvada will be available in the United States by September 2020, a year earlier than expected, according to Gilead Sciences. “Gilead reached an agreement with Teva Pharmaceuticals in 2014 to allow the early launch of a generic version of Truvada into the market in 2020, a year earlier than required,” Douglas Brooks, Gilead executive director for community engagement, wrote in an email...